EndeavorRx in AI answers

EndeavorRx is the first FDA-authorized prescription digital therapeutic for improving attention in children aged 8–12 with ADHD (primarily inattentive or combined-type). It is indicated to improve attention as measured by computer-based testing such as TOVA and should be used as part of a broader therapeutic program under a clinician's supervision, not as a stand-alone treatment or substitute for medication. In clinical studies, adverse events were generally mild and transient (around 9% treatment-related) with no serious adverse events; the product is Rx-only.